跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 42,317 条关于
“anxiety disorder”
全部
42,317
临床试验
38,051
药物
319
机构
19
资讯
3,928
去年
Vistagen Initiates Phase 2 Repeat Dose Study of Fasedienol for Social Anxiety Disorder
10个月前
Neuphoria Therapeutics Advances BNC-210 Phase 3 Trial for Social Anxiety Disorder
去年
Neuphoria Therapeutics Completes Phase 3 Enrollment for BNC-210 Social Anxiety Disorder Treatment
11个月前
First Health Canada-Approved Phase 2 Trial Investigates Psilocybin Microdosing for Generalized Anxiety Disorder
去年
VistaGen's Fasedienol Shows Promise in Phase 3 Trials for Social Anxiety Disorder
去年
Vistagen Advances Fasedienol Phase 3 Program for Social Anxiety Disorder with Q4 2025 Data Readout
2个月前
Market Rotation Fuels Biotech Surge as AI Trade Falters; Definium Therapeutics Rises on Anxiety Disorder Catalyst
去年
MindMed Initiates Phase III Trial of MM120 (LSD) for Generalized Anxiety Disorder
2年前
MindMed's MM120 Receives FDA Breakthrough Therapy Designation for Generalized Anxiety Disorder
去年
Vistagen Advances Social Anxiety Disorder Treatment with Fasedienol Phase 3 Trials
第 1 页,共 393 页
上一页
下一页